Condition 101 About Acromegaloid Facial Appearance Syndrome

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Top Global Doctors For Acromegaloid Facial Appearance Syndrome

View All Doctors

Latest Advances On Acromegaloid Facial Appearance Syndrome

  • Condition: Refractory Pituitary Adenomas and Pituitary Carcinomas
  • Journal: Frontiers in endocrinology
  • Treatment Used: Immunotherapy
  • Number of Patients: 0
  • Published —
The study researched the use of immunotherapy in patients with refractory pituitary adenomas and pituitary carcinomas.
  • Condition: Acromegaly
  • Journal: BMC endocrine disorders
  • Treatment Used: Somatostatin Analogues (SAs) with Pegvisomant
  • Number of Patients: 0
  • Published —
This study evaluated the effectiveness of combined therapy with somatostatin analogues (drugs that block the extra release of hormones) with pegvisomant for the treatment of acromegaly (when the pituitary gland produces too much growth hormone during adulthood).
View All Latest Advances

Clinical Trials For Acromegaloid Facial Appearance Syndrome

Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 40
  • Start Date: January 4, 2021
An Open Label, Randomized, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of IONIS-GHR-LRx, an Antisense Inhibitor of the Growth Hormone Receptor, Administered Monthly as Monotherapy in Patients With Acromegaly
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Drug
  • Participants: 10
  • Start Date: September 1, 2020
A Pilot Study of Empagliflozin in the Treatment of Acromegalic Cardiomyopathy
View All Clinical Trials